Breaking through BCL-2 inhibition in CLL

Blood. 2020 Mar 5;135(10):709-711. doi: 10.1182/blood.2019004767.
No abstract available

Publication types

  • Comment

MeSH terms

  • Bridged Bicyclo Compounds, Heterocyclic
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell*
  • Mutation
  • Proto-Oncogene Proteins c-bcl-2
  • Sulfonamides

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Proto-Oncogene Proteins c-bcl-2
  • Sulfonamides
  • venetoclax